Due to COVID-19 the clinical trial industry has been adopting advanced clinical trial technology at warp speed, but what does this mean for the future? What is a sustainable approach to ensure the industry does not face the same challenges and delays should we be impacted by another pandemic or global crisis? In this podcast we sit down with Mary Mattes, Senior Vice President of Global Operations at Synteract to discuss decentralization of clinical trials and a hybrid model.
Phastar and Medrio have been partnering together on trials for the past 3 years, culminating in a unique way to visualize clinical trial data....
ClinData is a leading South African CRO focused on Animal Health studies, they recently eradicated paper from 21 studies with plans to move more...
Patients are no longer passive research subjects, but rather being integrated into the research process from the start. Patient advocates help with such integrations,...
